Barrett Burke Thomas 4
4 · Pulse Biosciences, Inc. · Filed Jun 24, 2024
Insider Transaction Report
Form 4
Barrett Burke Thomas
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2024-05-12+700,000→ 700,000 totalExercise: $7.45Exp: 2034-05-12→ Common Stock (700,000 underlying) - Award
Stock Option (right to buy)
2024-05-12+700,000→ 700,000 totalExercise: $7.45Exp: 2034-05-12→ Common Stock (700,000 underlying)
Footnotes (2)
- [F1]The shares will vest in four equal annual installments on each of the first four annual anniversaries of the grant date, subject to the Reporting Person's continued service through each vesting date.
- [F2]The shares subject to this option are subject to five tranches of performance-based vesting criteria tied to Issuer's market capitalization, with no vesting until the Issuer's market capitalization exceeds $1 billion, in all cases, subject to the Reporting Person's continued service through each vesting milestone.